SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Robless Peter)
 

Sökning: WFRF:(Robless Peter) > Global vascular gui...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00006487naa a2201069 4500
001oai:DiVA.org:uu-404277
003SwePub
008200217s2019 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4042772 URI
024a https://doi.org/10.1016/j.jvs.2019.02.0162 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Conte, Michael S4 aut
2451 0a Global vascular guidelines on the management of chronic limb-threatening ischemia.
264 1b Elsevier BV,c 2019
338 a print2 rdacarrier
520 a Chronic limb-threatening ischemia (CLTI) is associated with mortality, amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are focused on definition, evaluation, and management of CLTI with the goals of improving evidence-based care and highlighting critical research needs. The term CLTI is preferred over critical limb ischemia, as the latter implies threshold values of impaired perfusion rather than a continuum. CLTI is a clinical syndrome defined by the presence of peripheral artery disease (PAD) in combination with rest pain, gangrene, or a lower limb ulceration >2 weeks duration. Venous, traumatic, embolic, and nonatherosclerotic etiologies are excluded. All patients with suspected CLTI should be referred urgently to a vascular specialist. Accurately staging the severity of limb threat is fundamental, and the Society for Vascular Surgery Threatened Limb Classification system, based on grading of Wounds, Ischemia, and foot Infection (WIfI) is endorsed. Objective hemodynamic testing, including toe pressures as the preferred measure, is required to assess CLTI. Evidence-based revascularization (EBR) hinges on three independent axes: Patient risk, Limb severity, and ANatomic complexity (PLAN). Average-risk and high-risk patients are defined by estimated procedural and 2-year all-cause mortality. The GVG proposes a new Global Anatomic Staging System (GLASS), which involves defining a preferred target artery path (TAP) and then estimating limb-based patency (LBP), resulting in three stages of complexity for intervention. The optimal revascularization strategy is also influenced by the availability of autogenous vein for open bypass surgery. Recommendations for EBR are based on best available data, pending level 1 evidence from ongoing trials. Vein bypass may be preferred for average-risk patients with advanced limb threat and high complexity disease, while those with less complex anatomy, intermediate severity limb threat, or high patient risk may be favored for endovascular intervention. All patients with CLTI should be afforded best medical therapy including the use of antithrombotic, lipid-lowering, antihypertensive, and glycemic control agents, as well as counseling on smoking cessation, diet, exercise, and preventive foot care. Following EBR, long-term limb surveillance is advised. The effectiveness of nonrevascularization therapies (eg, spinal stimulation, pneumatic compression, prostanoids, and hyperbaric oxygen) has not been established. Regenerative medicine approaches (eg, cell, gene therapies) for CLTI should be restricted to rigorously conducted randomizsed clinical trials. The GVG promotes standardization of study designs and end points for clinical trials in CLTI. The importance of multidisciplinary teams and centers of excellence for amputation prevention is stressed as a key health system initiative.
653 a Bypass surgery
653 a Chronic limb-threatening ischemia
653 a Critical limb ischemia
653 a Diabetes
653 a Endovascular intervention
653 a Evidence-based medicine
653 a Foot ulcer
653 a Peripheral artery disease
653 a Practice guideline
700a Bradbury, Andrew W4 aut
700a Kolh, Philippe4 aut
700a White, John V4 aut
700a Dick, Florian4 aut
700a Fitridge, Robert4 aut
700a Mills, Joseph L4 aut
700a Ricco, Jean-Baptiste4 aut
700a Suresh, Kalkunte R4 aut
700a Murad, M Hassan4 aut
700a Aboyans, Victor4 aut
700a Aksoy, Murat4 aut
700a Alexandrescu, Vlad-Adrian4 aut
700a Armstrong, David4 aut
700a Azuma, Nobuyoshi4 aut
700a Belch, Jill4 aut
700a Bergoeing, Michel4 aut
700a Björck, Martinu Uppsala universitet,Kärlkirurgi4 aut0 (Swepub:uu)mabjo425
700a Chakfé, Nabil4 aut
700a Cheng, Stephen4 aut
700a Dawson, Joseph4 aut
700a Debus, Eike Sebastian4 aut
700a Dueck, Andrew4 aut
700a Duval, Susan4 aut
700a Eckstein, Hans Henning4 aut
700a Ferraresi, Roberto4 aut
700a Gambhir, Raghvinder4 aut
700a Gargiulo, Mauro4 aut
700a Geraghty, Patrick4 aut
700a Goode, Steve4 aut
700a Gray, Bruce4 aut
700a Guo, Wei4 aut
700a Gupta, Prem Chand4 aut
700a Hinchliffe, Robert4 aut
700a Jetty, Prasad4 aut
700a Komori, Kimihiro4 aut
700a Lavery, Lawrence4 aut
700a Liang, Wei4 aut
700a Lookstein, Robert4 aut
700a Menard, Matthew4 aut
700a Misra, Sanjay4 aut
700a Miyata, Tetsuro4 aut
700a Moneta, Greg4 aut
700a Prado, Jose Antonio Munoa4 aut
700a Munoz, Alberto4 aut
700a Paolini, Juan Esteban4 aut
700a Patel, Manesh4 aut
700a Pomposelli, Frank4 aut
700a Powell, Richard4 aut
700a Robless, Peter4 aut
700a Rogers, Lee4 aut
700a Schanzer, Andres4 aut
700a Schneider, Peter4 aut
700a Taylor, Spence4 aut
700a Vega De Ceniga, Melina4 aut
700a Veller, Martin4 aut
700a Vermassen, Frank4 aut
700a Wang, Jinsong4 aut
700a Wang, Shenming4 aut
710a Uppsala universitetb Kärlkirurgi4 org
773t Journal of Vascular Surgeryd : Elsevier BVg 69:6S, s. 3S-125S.e40q 69:6S<3S-125S.e40x 0741-5214x 1097-6809
856u http://www.jvascsurg.org/article/S0741521419303210/pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-404277
8564 8u https://doi.org/10.1016/j.jvs.2019.02.016

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy